デフォルト表紙
市場調査レポート
商品コード
1701717

目の健康サプリメントの市場規模、シェア、成長分析、成分タイプ別、適応症別、製剤別、流通チャネル別、地域別 - 産業予測 2025~2032年

Eye Health Supplements Market Size, Share, and Growth Analysis, By Ingredient Type, By Indication (Age-related Macular Degeneration, Cataract), By Formulation, By Distribution Channel, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 219 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
目の健康サプリメントの市場規模、シェア、成長分析、成分タイプ別、適応症別、製剤別、流通チャネル別、地域別 - 産業予測 2025~2032年
出版日: 2025年04月06日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

目の健康サプリメント市場規模は2023年に25億米ドルと評価され、2024年の26億7,000万米ドルから2032年には44億8,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは6.7%で成長する見通しです。

目の健康サプリメント市場は、視力障害と近視の有病率の増加、特にCOVID-19流行時のスクリーン使用時間の増加による悪化によって大きな成長を遂げています。白内障、緑内障、加齢黄斑変性(AMD)などの疾患は、特に高齢化社会とデジタルネイティブのミレニアル世代で一般的になりつつあります。特に、世界保健機関(WHO)の報告によると、世界中で約22億人が視力の問題に苦しんでおり、その影響は中低所得国に偏っています。ルテイン、ゼアキサンチン、その他のサプリメントに対する需要の高まりとともに、先進国における個人消費の開拓が、市場の拡大をさらに後押ししています。オンライン販売チャネルへのシフトにより、アイサプリメントのeコマース売上は最近48.3%近く増加しており、米国市場の前向きな成長軌道を強化しています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 規制情勢
  • ケーススタディ
  • 技術分析

目の健康サプリメント市場規模:成分タイプ別& CAGR(2025-2032)

  • 市場概要
  • ルテインとゼアキサンチン
  • 抗酸化物質
  • オメガ3脂肪酸
  • コエンザイムQ10
  • フラボノイド
  • アルファリポ酸
  • アスタキサンチン
  • その他

目の健康サプリメント市場規模:適応症別& CAGR(2025-2032)

  • 市場概要
  • 加齢黄斑変性症(AMD)
  • 白内障
  • ドライアイ症候群
  • 炎症
  • その他

目の健康サプリメント市場規模:製剤別& CAGR(2025-2032)

  • 市場概要
  • タブレット
  • カプセル
  • 粉末
  • ソフトジェル
  • 液体
  • その他

目の健康サプリメント市場規模:流通チャネル別& CAGR(2025-2032)

  • 市場概要
  • 病院薬局
  • 小売薬局
  • ハイパーマーケットとスーパーマーケット
  • eコマース

目の健康サプリメント市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022-2024年)

主要企業プロファイル

  • Santen Pharmaceutical(Japan)
  • Rohto Pharmaceutical(Japan)
  • Dompe Farmaceutici(Italy)
  • Vianex S.A.(Greece)
  • Abbott Laboratories(USA)
  • Bausch+Lomb(USA)
  • Alcon(Switzerland)
  • Pfizer Inc.(USA)
  • Novartis AG(Switzerland)
  • Thea Pharma(France)
  • Similasan AG(Switzerland)
  • Jamieson Wellness(Canada)
  • Nature's Way(USA)
  • NOW Foods(USA)
  • Nature's Bounty(USA)
  • GNC Holdings(USA)
  • Herbalife Nutrition(USA)
  • Amway(USA)
  • Pharma Nord(Denmark)
  • Solgar(USA)

結論と提言

目次
Product Code: SQMIG35I2201

Eye Health Supplements Market size was valued at USD 2.5 billion in 2023 and is poised to grow from USD 2.67 billion in 2024 to USD 4.48 billion by 2032, growing at a CAGR of 6.7% during the forecast period (2025-2032).

The eye health supplements market is experiencing significant growth driven by the increasing prevalence of vision impairment and myopia, particularly exacerbated by heightened screen time during the COVID-19 pandemic. Conditions such as cataracts, glaucoma, and age-related macular degeneration (AMD) are becoming more common, especially among the aging population and digital-native millennials. Notably, the World Health Organization reports that approximately 2.2 billion people globally struggle with vision issues, with a disproportionate impact in low to middle-income countries. Rising consumer spending in developed nations, alongside the growing demand for Lutein, Zeaxanthin, and other supplements, further propels market expansion. The shift towards online sales channels has significantly increased accessibility, with e-commerce sales of eye supplements up nearly 48.3% recently, reinforcing a positive growth trajectory for the U.S. eye health supplements market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Eye Health Supplements market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Eye Health Supplements Market Segments Analysis

Global Eye Health Supplements Market is segmented by Ingredient Type, Indication, Formulation, Distribution Channel and region. Based on Ingredient Type, the market is segmented into Lutein & Zeaxanthin, Antioxidants, Omega-3 Fatty Acids, Coenzyme Q10, Flavonoids, Alpha-Lipoic Acid, Astaxanthin and Others. Based on Indication, the market is segmented into Age-related Macular Degeneration (AMD), Cataract, Dry Eye Syndrome, Inflammation and Others. Based on Formulation, the market is segmented into Tablets, Capsules, Powder, Softgels, Liquid and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Hypermarkets & Supermarkets and E-Commerce. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Eye Health Supplements Market

The increasing occurrence of eye-related conditions, including age-related macular degeneration (AMD), cataracts, and dry eye syndrome, is fueling the demand for eye health supplements. With a rapidly aging global population, the prevalence of these disorders is anticipated to grow, leading to an expanding market for supplements designed to promote and maintain eye health. As individuals become more aware of the importance of eye care, there is a greater inclination towards preventative measures, further driving the need for effective eye health supplements. This trend highlights the significant opportunity within the market as consumers seek to protect their vision and overall ocular well-being.

Restraints in the Eye Health Supplements Market

The Eye Health Supplements market faces a significant restraint due to the limited scientific evidence surrounding their effectiveness and long-term consequences. Although anecdotal accounts and some preliminary research suggest potential benefits, the absence of comprehensive clinical studies and consistent research methodologies poses a challenge. This inadequacy can undermine consumer trust and willingness to embrace these products, as many individuals may hesitate to invest in supplements when the scientific backing is not sufficiently robust. Consequently, the market may struggle to gain traction as consumers seek more credible information before making purchasing decisions related to eye health supplements.

Market Trends of the Eye Health Supplements Market

The Eye Health Supplements market is witnessing a significant trend driven by increasing consumer awareness regarding ocular wellness and the prevention of age-related conditions like macular degeneration and cataracts. As more individuals embrace proactive health management, the demand for eye health supplements is surging, with consumers incorporating these products into their daily wellness routines to support optimal vision and overall eye function. This trend is further fueled by the proliferation of information on the benefits of nutrients like lutein, zeaxanthin, and omega-3 fatty acids, positioning eye health supplements as essential components of holistic health strategies in an increasingly health-conscious market.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies
  • Technology Analysis

Global Eye Health Supplements Market Size by Ingredient Type & CAGR (2025-2032)

  • Market Overview
  • Lutein & Zeaxanthin
  • Antioxidants
  • Omega-3 Fatty Acids
  • Coenzyme Q10
  • Flavonoids
  • Alpha-Lipoic Acid
  • Astaxanthin
  • Others

Global Eye Health Supplements Market Size by Indication & CAGR (2025-2032)

  • Market Overview
  • Age-related Macular Degeneration (AMD)
  • Cataract
  • Dry Eye Syndrome
  • Inflammation
  • Others

Global Eye Health Supplements Market Size by Formulation & CAGR (2025-2032)

  • Market Overview
  • Tablets
  • Capsules
  • Powder
  • Softgels
  • Liquid
  • Others

Global Eye Health Supplements Market Size by Distribution Channel & CAGR (2025-2032)

  • Market Overview
  • Hospital Pharmacy
  • Retail Pharmacy
  • Hypermarkets & Supermarkets
  • E-Commerce

Global Eye Health Supplements Market Size & CAGR (2025-2032)

  • North America (Ingredient Type, Indication, Formulation, Distribution Channel)
    • US
    • Canada
  • Europe (Ingredient Type, Indication, Formulation, Distribution Channel)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Ingredient Type, Indication, Formulation, Distribution Channel)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Ingredient Type, Indication, Formulation, Distribution Channel)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Ingredient Type, Indication, Formulation, Distribution Channel)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Santen Pharmaceutical (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rohto Pharmaceutical (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dompe Farmaceutici (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vianex S.A. (Greece)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bausch + Lomb (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alcon (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thea Pharma (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Similasan AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jamieson Wellness (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nature's Way (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NOW Foods (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nature's Bounty (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GNC Holdings (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Herbalife Nutrition (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amway (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pharma Nord (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Solgar (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations